It is a central anticholinergic anti-Parkinson’s disease drug, which acts by selectively blocking the cholinergic neural pathway in the striatum with less effect on the periphery, thus facilitating the restoration of the balance of dopamine and acetylcholine in the brain of Parkinson’s disease patients, and improving the symptoms of Parkinson’s disease in patients.